Hong Kong Exchanges and Clearing Limited

FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation

Form Serial Number:

DA20230222E00052

1. Date of relevant event:

20/02/2023
(dd/mm/yyyy)

2. Date when director became aware of the relevant event/ interest in the shares (if later):

(dd/mm/yyyy)

3. Stock code:

02179

4. Name of listed corporation:

Jiangsu Recbio Technology Co., Ltd. - B - H Shares

5. Class of shares:

H Shares

6. Number of issued shares in class:

316,138,689

7. Name of director (English) as printed on HKID Card/Passport:

(Surname)	FENG
(Other names)	TAO

10. Name of director (Chinese):

逢涛

11. Chinese Character Code as printed on HKID Card:

24. Details of relevant event:

Brief description of relevant event

Capacity in which shares were/are held

Number of shares bought/sold or involved

Currency of transaction

On Exchange

Off Exchange

Before relevant event

After relevant event

Highest price (per share)

Average price (per share)

Average consideration (per share)

Consideration code

Long position

1113	The number of shares in which you are interested has increased because: any other event (you must briefly describe the relevant event in the Supplementary Information box)

2201	Interest of corporation controlled by you

18,135,827

Short position

25. Total shares in listed corporation immediately before the relevant event:

	Total number of shares	Percentage figure (%)
Long position	0	0.00

26. Total shares in listed corporation immediately after the relevant event:

	Total number of shares	Percentage figure (%)
Long position	18,135,827	5.74

27. Capacity in which interests disclosed in Box 26 are held:

Code describing capacity

Number of shares

2201	Interest of corporation controlled by you

Long position

18,135,827

28. Further information in derivative interests in listed corporation :

Derivatives code

Exercise period (dd/mm/yyyy)

Consideration - if derivatives granted by listed corporation

Number of shares

		Begins	Ends	Currency	Price for grant	Currency	Exercise price	Currency	Price on assignment

29. Further information in relation to interests of children under 18 and/or spouse:

Child/Spouse	Name of child/spouse	Number of shares

30. Further information in relation to interests of corporations controlled by Director:

Name of controlled corporation

Address and place of incorporation

Name of controlling person

% control

Direct interest (Y/N)

Number of shares

Shenzhen Huizhi Gongying Enterprise Management Partnership (Limited Partnership) (深圳市匯智共盈企業管理合夥企業(有限合夥))

Zone B, Room 702, 7/F, Cable Communications Building, 3369 Binhai Road, Haizhu Community, Yuehai Street, Nanshan District, Shenzhen, the People's Republic of China (中國深圳市南山區粵海街道海珠社區濱海大道3369號有線信息傳輸大廈7層702室B區) (People's Republic of China)

FENG Tao (as general partner)

100.00

Long position

18,135,827

Shenzhen Fer-Capital Investment Co., Ltd. (深圳前海沃盈投資管理有限公司)

Room 201, Block A, 1 One Qianwan Road, Qianhai Shenzhen-Hong Kong Cooperation Zone, Shenzhen, the People's Republic of China (中國深圳市前海深港合作區前灣一路1號A棟201室(入駐深圳市前海商務秘書有限公司)) (People's Republic of China)

Shenzhen Huizhi Gongying Enterprise Management Partnership (Limited Partnership) (深圳市匯智共盈企業管理合夥企業(有限合夥))

10.00

Long position

18,135,827

Shenzhen Fer-Capital Investment Co., Ltd. (深圳前海沃盈投資管理有限公司)

FENG Tao

42.80

Long position

18,135,827

Shenzhen Yingkejin Investment Management Partnership (Limited Partnership) (深圳盈科進投資管理合夥企業(有限合夥))

Room 702, 7/F, Cable Communications Building, 85 Houhai Wenxin Road, Yuehai Street, Nanshan District, Shenzhen, the People's Republic of China (中國深圳市南山區粵海街道海珠社區后海文心路85號有線信息傳輸大廈7層702室) (People's Republic of China)

Shenzhen Fer-Capital Investment Co., Ltd. (深圳前海沃盈投資管理有限公司) (as general partner)

100.00

Long position

9,050,787

Liuyang Woyang Health Industry Investment Partnership (Limited Partnership) (瀏陽沃陽健康產業投資合夥企業(有限合夥))

109 Kangping Road, Jingkai District, Liuyang, the People's Republic of China (Room 416, Hunan Jinyang Investment Group Company Limited) (中國瀏陽經開區康平路109號(湖南金陽投資集團有限公司416室)) (People's Republic of China)

Shenzhen Fer-Capital Investment Co., Ltd. (深圳前海沃盈投資管理有限公司) (as general partner)

100.00

Long position

4,163,360

Changsha Woyang Phase II Health Industry Investment Partnership (Limited Partnership) (長沙沃陽二期健康產業投資合夥企業(有限合夥))

109 Kangping Road, Jingkai District, Liuyang, the People's Republic of China (Room 319, Hunan Jinyang Investment Group Company Limited) (中國瀏陽經開區康平路109號(湖南金陽投資集團有限公司319室)) (People's Republic of China)

Shenzhen Fer-Capital Investment Co., Ltd. (深圳前海沃盈投資管理有限公司) (as general partner)

100.00

Long position

4,062,573

Shenzhen Luewei Investment Management Partnership (Limited Partnership) (深圳略威投資管理合夥企業(有限合夥))

Shenzhen Fer-Capital Investment Co., Ltd. (深圳前海沃盈投資管理有限公司) (as general partner)

100.00

Long position

859,107

31. Further information in relation to interests held by Director jointly with another person:

Name of joint shareholder	Address	Number of shares

32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:

Names of Trust	Address	Status code	Number of shares

33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):

Names of other parties	Address	Number of shares

Total number of shares in which a director is interested under sections 317 and 318

34. Supplementary information:

Jiangsu Recbio Technology Co., Ltd. (the "Company") completed the conversion of its 222,498,569 unlisted domestic shares into its H shares (the "Conversion"). And in the Conversion, the 18,135,827 unlisted domestic shares held by Mr. FENG Tao (see the corporations in column 30) were converted to H shares. Please refer to Company's announcements dated 5 December 2022 and 20 February 2023 for more details.

35. Log/Serial Number of the previous form:

36. Number of concert party document(s) under section 317 attached/uploaded:

Date of filing this Form 3A:

22/02/2023
(dd/mm/yyyy)